跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Paclitaxel/Cisplatin
首页
药物
Paclitaxel/Cisplatin
Paclitaxel/Cisplatin
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Method of treating cancer by a combined therapy of YM-155 with other anticancer agents
EP 2609920 A1
申请人: ASTELLAS PHARMA INC
优先权: 2006
EP
US
6 件公开
Device and methods for sequential, regional delivery of multiple cytotoxic agents and directed assembly of wound repair tissues
US 7326421 B2
申请人: KENSEY NASH CORP
优先权: 2003
US
6 件公开
MALIGNANT NEOPLASIS TREATMENT USING PD-1 ANTIBODY COMBINATION
EP 4319736 A1
申请人: BIOCAD JOINT STOCK CO
优先权: 2021
CN
EP
WO
3 件公开
METHOD AND COMPOSITION FOR RENDERING CANCER CELLS SUSCEPTIBLE TO TREATMENT BY TARGETED ONCOGENETIC DRIVERS
EP 4433046 A4
申请人: IMPACT BIOLIFE SCIENCE INC
优先权: 2021
CN
EP
WO
3 件公开
Method and compositions for treatment of cancer
CN 104997808 A
申请人: KOMINOX INC
优先权: 2008
CN
US
3 件公开
Compounds and methods to sensitize cancer cells to cisplatin
US 12121510 B2
申请人: CEDARS SINAI MEDICAL CENTER
优先权: 2016
CN
US
3 件公开
Product comprising at least one phosphatase cdc25 inhibitor combined with at least one other anticancer agent
US 2006281736 A1
申请人: PREVOST GREGOIRE
优先权: 2003
US
3 件公开
FGFR1 extracellular domain combination therapies for lung cancer
US 8951972 B2
申请人: LONG LI
优先权: 2011
US
3 件公开
Pharmaceutical composition for preventing or treating cancer, comprising gossypol, phenformin, and anticancer agent
US 12194007 B2
申请人: NAT CANCER CT
优先权: 2018
US
3 件公开
Drug combinations with substituted diaryl ureas for the treatment of cancer
EP 2338488 A1
申请人: BAYER HEALTHCARE LLC
优先权: 2007
EP
US
2 件公开
第 1 / 6 页
上一页
下一页
药物
反馈